Zepbound (tirzepatide) works as a dual GIP and GLP-1 receptor agonist to reduce appetite and promote weight loss through effects on the digestive system and brain pathways regulating food intake
Investigators also have hypothesized that cyclosporine can modify resistance to chemotherapy by augmenting the cytotoxic effect of drugs through inducing a GSH deficiency
Thinking About GLP-1 for Weight Loss
More serious concerns include pancreatitis, gallbladder disease, and acute kidney injury
These initial studies in CA1 inhibitory neurons also demonstrate that plasticity rules and mechanisms in interneurons can be: (a) different from those known for pyramidal cells, e.g., NMDA-independent (Perez et al., 2001
The first, called EnReachRx, is a new patient support program designed for pharmacies that are committed to providing enhanced clinical services alongside dispensing GLP-1 drugs